CAT-3888

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameCAT-3888
Drug Alias NameRFB4 (dsFv) PE38BL22 Immunotoxin - MedImmune LLCGCR 3888BL 22CAT-3888 +[6] 
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionImmunomodulatorsCD22 modulators
TargetsCD22
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCambridge Antibody TechnologyMedimmune LlcNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A